SCHEMBL15599405

SCHEMBL15599405

B[n+]1c(NCCC)nc(N(CC)OCc2ccccc2)nc1NCCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
TLR8 Q9NR97 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
APP P05067 3/20 0.33
BCHE P06276 2/20 0.33
ACHE P22303 2/20 0.33
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
ALDH1A1 P00352 2/20 0.32
BLM P54132 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MERTK Q12866 1/20 0.31
HTT P42858 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
HTR1A P08908 1/20 0.31
ADRA1D P25100 1/20 0.31
ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9104029 0.82 APP (0.44) CYP1A2APPBCHEACHEPDE4A
Sulfuric Acid SCHEMBL9102371 0.76 CA1 (0.41) APPBCHEACHEPDE4APDE4B
Sulfuric Acid SCHEMBL9102382 0.74 CA1 (0.42) APPBCHEACHEHTTLMNA
SCHEMBL9106762 0.68 APP (0.48) APPBCHEACHEALDH1A1HTT
SCHEMBL9104042 0.66 HTT (0.38) BCHEALDH1A1L3MBTL1HTTSMN1; SMN2
SCHEMBL9103232 0.65 APP (0.42) CYP1A2CYP2D6APPBCHEACHE
Sulfuric Acid SCHEMBL9105681 0.63 CA1 (0.44) APPBCHEACHESMN1; SMN2
Sulfuric Acid SCHEMBL9105688 0.61 CA1 (0.45) APPBCHEACHEALDH1A1HTT
SCHEMBL29151842 0.61 APP (0.49) CYP1A2APPBCHEACHEHTT
SCHEMBL10872451 0.60 BCHE (0.42) BCHEL3MBTL1HTTSMN1; SMN2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013181217-A2 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES GALLEON PHARMACEUTICALS, INC. (US) 2013-12-05 WO disclosed